Feb 4, 2020

Bloom Science Granted Exclusive Option to License ALS Microbiome-based Gut Therapies

Posted by in categories: biotech/medical, genetics, science

Bloom Science and Duke University have entered into an exclusive licensing agreement that provides the biopharmaceutical company access to the intellectual property and technology related to unique strain isolates and genetic variants of Akkermansia genus bacteria.

This type of bacteria has been demonstrated to slow disease progression and prolong survival in animal models of amyotrophic lateral sclerosis (ALS).

Comments are closed.